Om­nibus spend­ing bill fea­tures fund­ing to bol­ster the sup­ply chain and site in­spec­tions

Af­ter com­mit­ting about $2 bil­lion for new bio­man­u­fac­tur­ing ef­forts, next year’s $1.7 tril­lion gov­ern­ment spend­ing bill fea­tures new phar­ma man­u­fac­tur­ing ef­forts.

In ad­di­tion to cre­at­ing Na­tion­al Cen­ters of Ex­cel­lence in Ad­vanced and Con­tin­u­ous Phar­ma­ceu­ti­cal Man­u­fac­tur­ing, and pro­vid­ing $10 mil­lion for unan­nounced for­eign in­spec­tion pi­lot, oth­er pro­vi­sions will seek to mit­i­gate drug short­ages that have hit sev­er­al high-pro­file drugs re­cent­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER